Unveiling advanced moisture-retention polymer technology designed to accelerate natural cell migration and tissue regeneration.
As a premier China Hydrocolloid Dressings Manufacturer & Factory, we provide a sophisticated scientific approach to wound recovery. Hydrocolloid dressings represent a benchmark in advanced wound care management. Composed of an elastic, cohesive adhesive mass integrated with hydrophilic particles (such as sodium carboxymethylcellulose, pectin, and gelatin) laminated onto a semi-occlusive, waterproof polyurethane backing, these dressings optimize the physiologic healing process.
Upon contacting wound exudates, the hydrophilic components swell and transform into a cohesive, moisture-retentive gel. This gel establishes an optimal damp microenvironment, encouraging autolytic debridement, speeding up angiogenesis, and protecting newly generated granulation tissue. The outer polyurethane layer serves as a microbial barrier, effectively sealing out exogenous pathogens while allowing natural vapor transfer.
Our manufacturing technology permits highly customized thickness configurations, high fluid absorption profiles, and variable shear resistance parameters. This enables the dressing to adapt seamlessly to challenging bodily contours, protecting patients from secondary damage during changes.
Our hydrocolloids balance moisture dynamics, absorbing excess exudate while retaining cellular factors crucial for tissue repair. This prevents scab formation, thereby reducing scarring risk and minimizing local nerve compression to reduce pain.
Hangzhou Ultrivex Medical Co., Ltd. is a professional Medical Disposable Protective Products Manufacturer dedicated to delivering reliable infection control solutions and healthcare safety equipment to global markets. Based in Hangzhou, China, the company specializes in the development, production, and supply of a wide range of disposable medical protective products designed for hospitals, laboratories, cleanrooms, and industrial hygiene environments.
Ultrivex Medical focuses on high-quality nonwoven materials and advanced manufacturing processes to ensure consistent product performance, safety, and comfort. Its product portfolio includes protective apparel, patient care disposables, and hygiene solutions that meet the evolving demands of infection prevention and control. All products are manufactured under strict quality management systems and comply with international standards to support safe and efficient medical operations.
Assessing the macro-demand shifts driving high-density polymer dressings toward OTC, clinical, and home care applications.
The global wound dressing market is transitioning rapidly from passive, dry wound dressings (such as standard cotton gauze) to smart, interactive, and bioactive dressings. Driven by an aging population, rising diabetes incidence, and an increasing focus on post-operative care, advanced wound dressings are in high demand. The hydrocolloid dressing market represents a cornerstone of this sector, enjoying widespread adoption in clinical settings and the over-the-counter (OTC) consumer skincare market.
In mature markets like North America and Europe, healthcare systems seek cost-effective wound care solutions that decrease hospitalization times and reduce nursing overheads. Hydrocolloid dressings, which can remain in place for up to 7 days, significantly lower dressing change frequencies compared to traditional gauze, resulting in lower clinical labor and supply costs.
Concurrently, the explosive growth of hydrocolloid acne patches in global cosmetics and skincare channels has opened up large-scale commercial opportunities. Modern factories must balance high-speed, sterile medical-grade roll-stock production with precision-die cutting and localized consumer packaging lines to capture these distinct market segments.
How we optimize material sourcing, automated processing, and quality validation to secure global commercial pipelines.
By producing advanced nonwovens and high-grade adhesive formulations in-house, we control quality and costs at every step of raw material preparation and final product assembly.
All operations comply with ISO 13485 requirements. Automated optical inspection systems run alongside cleanrooms to detect micro-contaminants or adhesive gaps in real-time.
Strategically located near major shipping hubs like Shanghai and Ningbo, we offer rapid ocean and air freight logistics, backed by priority customs clearance.
Leveraging high-speed rotary die-cutting machinery and proprietary hot-melt coating plants, our facilities achieve rapid throughput while maintaining precise dimensional tolerances within ±0.1mm. This reliable volume manufacturing capability allows global distributors and brands to scale up their inventory levels without quality variation or structural delays.
Engineering custom hydrocolloid matrices to meet clinical demands across diverse medical and commercial sectors.
Designed for post-op incisions and superficial pressure injuries. The moisture vapor transmission rate (MVTR) is optimized to handle mild-to-moderate exudate, preventing maceration while promoting fast re-epithelialization.
Ultra-thin, tapered-edge hydrocolloid acne patches that blend invisibly with skin tones. Formulated with active additions like salicylic acid, tea tree oil, or centella asiatica to soothe and speed up localized skin healing.
Heavy-duty, wear-resistant options developed for friction blisters, athletic abrasions, and military foot care. Strong adhesive formulas ensure the patch stays in place even under sweat and friction.
Anticipating material science advancements to manufacture the next generation of smart dressings.
Integrating plant-derived, eco-friendly carboxymethylcellulose (CMC) and biopolymers. This initiative aims to reduce carbon emissions while maintaining standard fluid-absorption capacity and clinical safety profiles.
Developing hydrocolloids that incorporate antimicrobial components (such as silver ions and honey) and natural therapeutic agents, designed to protect chronic wounds from microbial biofilm formation.
R&D focused on smart dressings featuring built-in, color-shifting pH and moisture indicators. These enable caregivers to monitor wound status visually without removing the dressing, avoiding unnecessary tissue disruption.
Navigating global regulatory demands is essential for seamless commercial operations. As a global exporter, we align all manufacturing stages with target market requirements. Our products carry international certifications, helping you avoid import obstacles:
We provide full technical documentation, certificates of analysis (CoA), and sterilization records (EO/Gamma), enabling clean customs entry and rapid market introductions.
With a strong commitment to innovation and customer satisfaction, Ultrivex Medical provides flexible OEM and ODM services tailored to distributors, healthcare institutions, and medical brands worldwide. The company continuously invests in technology upgrades and process optimization to enhance production efficiency and product reliability.
Driven by the mission to safeguard health and improve hygiene standards, Hangzhou Ultrivex Medical Co., Ltd. strives to be a trusted global partner in medical disposable protection and healthcare safety solutions.
Clear, clinical, and logistical answers to your wound care sourcing questions.
Our hydrocolloid medical dressings carry a shelf life of 3 to 5 years, depending on the barrier properties of the packaging. We use Ethylene Oxide (EO) or Gamma Irradiation sterilization methods, validated per ISO 11135 and ISO 11137 standards, to ensure high sterility levels.
Yes, we offer custom formulations. We can modify the ratio of synthetic elastomers and carboxymethylcellulose (CMC) to alter the adhesion force, ensuring gentle removal suitable for sensitive skin or pediatric use.
We provide full-service OEM support, including custom shapes (stars, hearts, circles), diverse thicknesses, active infusions (salicylic acid, tea tree oil, hydrocolloid matrices), custom backing printing, and retail-ready packaging.
All raw material batches undergo extensive biocompatibility evaluations in compliance with ISO 10993. This includes testing for cytotoxicity, sensitization, and intracutaneous reactivity, ensuring safe contact with compromised skin barriers.
For standard OEM requests, production is completed in 30 to 45 days after artwork and formulation approval. Reorders can be processed faster through planned inventory allocation agreements.
Ultrivex Medical
